OPTIMIZING MULTIDISCIPLINARY STRATEGIES FOR ALLEVIATING PELVIC DISCOMFORT IN WOMEN WITH PERSISTENT ENDOMETRIAL INFLAMMATION

Persistent endometrial inflammation, or chronic endometritis (CE), affects 12–25% of women seeking reproductive care, often manifesting as debilitating pelvic discomfort that disrupts daily life. In Uzbekistan, where CE is diagnosed in 10–18% of gynecological patients, fragmented care exacerbates suffering. This randomized controlled trial (RCT) explored innovative multidisciplinary strategies—targeted antibiotics, acupuncture, and mindfulness-based stress reduction (MBSR)—to relieve pelvic discomfort in 160 women aged 20–40 across Tashkent, Fergana, and Bukhara clinics from March 2023 to December 2024. Participants were randomized into four groups: antibiotics, acupuncture, integrated (antibiotics-acupuncture-MBSR), and usual care (control). Primary outcomes were discomfort severity (Pelvic Pain Impact Questionnaire, PPIQ) and inflammatory resolution (biopsy-confirmed). Secondary outcomes included emotional well-being (PHQ-9), fertility potential (ovulatory cycles), and intervention uptake at 8 weeks and 6 months. The integrated group reduced PPIQ scores by 50% (8.5 ± 1.5 to 4.3 ± 1.0, p<0.001) and achieved 80% inflammatory resolution versus 50% in controls (p<0.01). Acupuncture alone eased discomfort by 35%, and antibiotics resolved inflammation in 65%. Emotional well-being improved markedly in the integrated group (PHQ-9 6 ± 2 vs. 12 ± 3 in controls, p<0.001). These results champion a holistic approach, offering Uzbekistan a practical framework to enhance women’s health and informing global CE care.